Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Oct;55(10):739–744. doi: 10.1136/ard.55.10.739

Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.

H R Peeters 1, M Jongen-Lavrencic 1, G Vreugdenhil 1, A J Swaak 1
PMCID: PMC1010292  PMID: 8984939

Abstract

OBJECTIVE: To study whether recombinant human erythropoietin (r-hu-Epo) improves anaemia and reduces disease activity in patients with rheumatoid arthritis and anaemia of chronic disease (ACD). METHODS: A 52 week placebo controlled randomised double blind trial with r-hu-Epo was performed in 70 patients with active rheumatoid arthritis and ACD. Thirty four patients were treated with 240 U kg-1 r-hu-Epo subcutaneously, initially three doses weekly, while 36 patients received placebo. RESULTS: A significant increase of haemoglobin from a median of 112 to 135 g litre-1 occurred in the Epo group within six weeks and could be sustained with reduced doses (median 240 U kg-1 once weekly). Sustained benefit compared to placebo was also apparent by six weeks for disease activity, as indicated by the Paulus 20% response rate. Of patients in the Epo group, 32% eventually showed a Paulus 20% response, compared to 8% of the placebo group (P = 0.016). Significant differences in favour of the Epo group were also observed in the secondary disease activity measures Ritchie index, number of swollen joints, pain score, ESR, and patients' global assessment of disease activity. C reactive protein concentrations did not change significantly. CONCLUSIONS: Treatment of ACD in rheumatoid arthritis with r-hu-Epo is effective in restoring normal haemoglobin levels and also exerts a beneficial effect on disease activity.

Full text

PDF
739

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Baer A. N., Dessypris E. N., Goldwasser E., Krantz S. B. Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol. 1987 Aug;66(4):559–564. doi: 10.1111/j.1365-2141.1987.tb01344.x. [DOI] [PubMed] [Google Scholar]
  3. Biemond P., Swaak A. J., van Eijk H. G., Koster J. F. Intraarticular ferritin-bound iron in rheumatoid arthritis. A factor that increases oxygen free radical-induced tissue destruction. Arthritis Rheum. 1986 Oct;29(10):1187–1193. doi: 10.1002/art.1780291002. [DOI] [PubMed] [Google Scholar]
  4. Blake D. R., Gallagher P. J., Potter A. R., Bell M. J., Bacon P. A. The effect of synovial iron on the progression of rheumatoid disease. A histologic assessment of patients with early rheumatoid synovitis. Arthritis Rheum. 1984 May;27(5):495–501. doi: 10.1002/art.1780270503. [DOI] [PubMed] [Google Scholar]
  5. Cartwright G. E., Lee G. R. The anaemia of chronic disorders. Br J Haematol. 1971 Aug;21(2):147–152. doi: 10.1111/j.1365-2141.1971.tb03424.x. [DOI] [PubMed] [Google Scholar]
  6. Dixon J. S., Bird H. A., Sitton N. G., Pickup M. E., Wright V. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol. 1984;13(1):39–44. doi: 10.3109/03009748409102666. [DOI] [PubMed] [Google Scholar]
  7. Eschbach J. W. Erythropoietin 1991--an overview. Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):3–9. [PubMed] [Google Scholar]
  8. Faquin W. C., Schneider T. J., Goldberg M. A. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood. 1992 Apr 15;79(8):1987–1994. [PubMed] [Google Scholar]
  9. Felson D. T., Anderson J. J., Boers M., Bombardier C., Chernoff M., Fried B., Furst D., Goldsmith C., Kieszak S., Lightfoot R. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993 Jun;36(6):729–740. doi: 10.1002/art.1780360601. [DOI] [PubMed] [Google Scholar]
  10. Gudbjörnsson B., Hällgren R., Wide L., Birgegård G. Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin. Ann Rheum Dis. 1992 Jun;51(6):747–752. doi: 10.1136/ard.51.6.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hansen N. E. The anaemia of chronic disorders. A bag of unsolved questions. Scand J Haematol. 1983 Nov;31(5):397–402. doi: 10.1111/j.1600-0609.1983.tb01532.x. [DOI] [PubMed] [Google Scholar]
  12. Hochberg M. C., Arnold C. M., Hogans B. B., Spivak J. L. Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. Arthritis Rheum. 1988 Oct;31(10):1318–1321. doi: 10.1002/art.1780311016. [DOI] [PubMed] [Google Scholar]
  13. Hochberg M. C., Chang R. W., Dwosh I., Lindsey S., Pincus T., Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 1992 May;35(5):498–502. doi: 10.1002/art.1780350502. [DOI] [PubMed] [Google Scholar]
  14. Jelkmann W., Pagel H., Wolff M., Fandrey J. Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci. 1992;50(4):301–308. doi: 10.1016/0024-3205(92)90338-p. [DOI] [PubMed] [Google Scholar]
  15. Kimata H., Yoshida A., Ishioka C., Mikawa H. Effect of recombinant human erythropoietin on human IgE production in vitro. Clin Exp Immunol. 1991 Mar;83(3):483–487. doi: 10.1111/j.1365-2249.1991.tb05665.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kirwan J. R. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med. 1995 Jul 20;333(3):142–146. doi: 10.1056/NEJM199507203330302. [DOI] [PubMed] [Google Scholar]
  17. Krantz S. B. Pathogenesis and treatment of the anemia of chronic disease. Am J Med Sci. 1994 May;307(5):353–359. doi: 10.1097/00000441-199405000-00009. [DOI] [PubMed] [Google Scholar]
  18. LUNDIN P., PERSSON E., WEINFELD A. COMPARISON OF HEMOSIDERIN ESTIMATION IN BONE MARROW SECTIONS AND BONE MARROW SMEARS. Acta Med Scand. 1964 Mar;175:383–390. doi: 10.1111/j.0954-6820.1964.tb00586.x. [DOI] [PubMed] [Google Scholar]
  19. Magarò M., Zoli A., Altomonte L., Mirone L., Corvino G., Storti S., Marra R., Ricerca B. M., Pagano L., Di Cesare L. Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation. Ann Rheum Dis. 1990 Apr;49(4):268–269. doi: 10.1136/ard.49.4.268-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Maury C. P., Andersson L. C., Teppo A. M., Partanen S., Juvonen E. Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro. Ann Rheum Dis. 1988 Dec;47(12):972–978. doi: 10.1136/ard.47.12.972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McConkey B. It is said that elevated erythrocyte sedimentation rate and the elevation of C-reactive protein (CRP) may be indicators of continuing joint destruction in rheumatoid arthritis. What then is the explanation for joint destruction in some patients in whom there is no such apparent elevation of either the sedimentation rate of CRP? Br J Rheumatol. 1990 Apr;29(2):88–88. doi: 10.1093/rheumatology/29.2.88. [DOI] [PubMed] [Google Scholar]
  22. Means R. T., Jr, Krantz S. B. Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin. Blood. 1991 Nov 15;78(10):2564–2567. [PubMed] [Google Scholar]
  23. Means R. T., Jr, Olsen N. J., Krantz S. B., Dessypris E. N., Graber S. E., Stone W. J., O'Neil V. L., Pincus T. Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis Rheum. 1989 May;32(5):638–642. doi: 10.1002/anr.1780320519. [DOI] [PubMed] [Google Scholar]
  24. Muirden K. D., Senator G. B. Iron in the synovial membrane in rheumatoid arthritis and other joint diseases. Ann Rheum Dis. 1968 Jan;27(1):38–48. doi: 10.1136/ard.27.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Murphy E. A., Bell A. L., Wojtulewski J., Brzeski M., Madhok R., Capell H. A. Study of erythropoietin in treatment of anaemia in patients with rheumatoid arthritis. BMJ. 1994 Nov 19;309(6965):1337–1338. doi: 10.1136/bmj.309.6965.1337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nishiya K. Stimulation of human synovial cell DNA synthesis by iron. J Rheumatol. 1994 Oct;21(10):1802–1807. [PubMed] [Google Scholar]
  27. Paulus H. E., Egger M. J., Ward J. R., Williams H. J. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group. Arthritis Rheum. 1990 Apr;33(4):477–484. doi: 10.1002/art.1780330403. [DOI] [PubMed] [Google Scholar]
  28. Peeters H. R., Jongen-Lavrencic M., Raja A. N., Ramdin H. S., Vreugdenhil G., Breedveld F. C., Swaak A. J. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset. Ann Rheum Dis. 1996 Mar;55(3):162–168. doi: 10.1136/ard.55.3.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pettersson T., Rosenlöf K., Friman C., Mickos A., Teppo A. M., Fyhrquist F. Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation. Scand J Rheumatol. 1993;22(4):188–193. doi: 10.3109/03009749309099269. [DOI] [PubMed] [Google Scholar]
  30. Pincus T., Olsen N. J., Russell I. J., Wolfe F., Harris E. R., Schnitzer T. J., Boccagno J. A., Krantz S. B. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med. 1990 Aug;89(2):161–168. doi: 10.1016/0002-9343(90)90294-n. [DOI] [PubMed] [Google Scholar]
  31. Reddy P. S., Lewis M. The adverse effect of intravenous iron-dextran in rheumatoid arthritis. Arthritis Rheum. 1969 Aug;12(4):454–457. doi: 10.1002/art.1780120413. [DOI] [PubMed] [Google Scholar]
  32. Roodman G. D., Bird A., Hutzler D., Montgomery W. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp Hematol. 1987 Oct;15(9):928–935. [PubMed] [Google Scholar]
  33. Singh A. B., Singh M., Palekar S., Levy S., Nunn C., Mann R. A. The effects of recombinant human erythropoietin on the cell mediated immune response of renal failure patients. J Med. 1992;23(5):289–302. [PubMed] [Google Scholar]
  34. Smith R. J., Davis P., Thomson A. B., Wadsworth L. D., Fackre P. Serum ferritin levels in anemia of rheumatoid arthritis. J Rheumatol. 1977 Winter;4(4):389–392. [PubMed] [Google Scholar]
  35. Swaak A. J., Nieuwenhuizen C., Vreugdenhil G. Recombinant human erythropoietin (r-hu-EPO) treatment in patients with rheumatoid arthritis and anaemia of chronic disease (ACD) Clin Exp Rheumatol. 1994 Sep-Oct;12(5):577–577. [PubMed] [Google Scholar]
  36. Takashina N., Kondo H., Kashiwazaki S. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis. J Rheumatol. 1990 Jul;17(7):885–887. [PubMed] [Google Scholar]
  37. Vreugdenhil G., Manger B., Nieuwenhuizen C., Feelders R. A., van Eijk H. G., Swaak A. J. Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis. Ann Hematol. 1992 Dec;65(6):265–268. doi: 10.1007/BF01836071. [DOI] [PubMed] [Google Scholar]
  38. Vreugdenhil G., Wognum A. W., van Eijk H. G., Swaak A. J. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness. Ann Rheum Dis. 1990 Feb;49(2):93–98. doi: 10.1136/ard.49.2.93. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES